Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ENLON-PLUS

ATROPINE SULFATE; EDROPHONIUM CHLORIDE

Standard Dose
0.14MG/ML;10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ENLON-PLUS is listed in Drugs@FDA under application 019678 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ATROPINE SULFATE; EDROPHONIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 0.14MG/ML;10MG/ML Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2025-10-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview ENLON-PLUS is listed in Drugs@FDA under application 019678 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ATROPINE SULFATE; EDROPHONIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 0.14MG/ML;10MG/ML Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2025-10-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ENLON-PLUS (ATROPINE SULFATE; EDROPHONIUM CHLORIDE) | Drug Monograph | MedicHelpline